World's Best Scientists 2026 revealed!
Fernanda G. De Felice

Fernanda G. De Felice

Award Badge
Neuroscience
Brazil
2026

D-Index & Metrics

Neuroscience

D-Index
69
Citations
19004
World Ranking
2605
National Ranking
144

Research.com Recognitions

  • 2026 - Research.com Neuroscience in Brazil Leader Award
  • 2025 - Research.com Neuroscience in Brazil Leader Award

Overview

Fernanda G. De Felice is affiliated with the Federal University of Rio de Janeiro in Brazil. Their research spans multiple disciplines within medical and biological sciences, with a primary focus on medicine, biochemistry, genetics and molecular biology, and neuroscience.

The scientist's work is distributed among several subfields, including physiology, molecular biology, neurology, biological psychiatry, and endocrine and autonomic systems. Their studies emphasize understanding complex mechanisms related to brain function and metabolic regulation.

The main topics addressed in their research include:

  • Alzheimer's disease research and treatments
  • Neuroinflammation and neurodegeneration mechanisms
  • Adipose tissue and metabolism
  • Tryptophan and brain disorders
  • Mitochondrial function and pathology
  • Long-term effects of COVID-19
  • Diet and metabolism studies

Recent papers from Fernanda G. De Felice demonstrate a focus on neurodegenerative diseases and the impact of systemic factors on brain function. Notable publications include:

  • "Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer's disease" (2021) published in Translational Psychiatry
  • "Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System" (2020) published in Trends in Neurosciences
  • "Impaired insulin signalling and allostatic load in Alzheimer disease" (2022) published in Nature Reviews Neuroscience
  • "Correction of eIF2-dependent defects in brain protein synthesis, synaptic plasticity, and memory in mouse models of Alzheimer's disease" (2021) published in Science Signaling
  • "Palmitate Is Increased in the Cerebrospinal Fluid of Humans with Obesity and Induces Memory Impairment in Mice via Pro-inflammatory TNF-α" (2020) published in Cell Reports

Collaborations have played a significant role in their scientific output, with frequent co-authors including Sérgio T. Ferreira, Mychael V. Lourenco, Fernanda Tovar-Moll, Felipe C. Ribeiro, and Felipe Kenji Sudo.

Publication venues where Fernanda G. De Felice has appeared most frequently include:

  • Alzheimer's & Dementia
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Molecular Psychiatry
  • Journal of Neurochemistry
  • Neuropharmacology

Best Publications

  • Aβ Oligomers Induce Neuronal Oxidative Stress through an N-Methyl-D-aspartate Receptor-dependent Mechanism That Is Blocked by the Alzheimer Drug Memantine

    Fernanda G. De Felice;Fernanda G. De Felice;Pauline T. Velasco;Mary P. Lambert;Kirsten L. Viola

  • An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease–associated Aβ oligomers

    Theresa R. Bomfim;Leticia Forny-Germano;Luciana B. Sathler;Jordano Brito-Moreira

  • Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer's models

    Mychael V. Lourenco;Mychael V. Lourenco;Rudimar L. Frozza;Rudimar L. Frozza;Guilherme B. de Freitas;Guilherme B. de Freitas;Hong Zhang

  • Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of Aβ oligomers

    Fernanda G. De Felice;Marcelo N.N. Vieira;Theresa R. Bomfim;Helena Decker

  • Amyloid beta oligomers induce impairment of neuronal insulin receptors

    Wei Qin Zhao;Fernanda G. De Felice;Sara Fernandez;Hui Chen

  • Inflammation, Defective Insulin Signaling, and Mitochondrial Dysfunction as Common Molecular Denominators Connecting Type 2 Diabetes to Alzheimer Disease

    Fernanda G. De Felice;Sergio T. Ferreira

  • Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers

    Fernanda G. De Felice;Diana Wu;Mary P. Lambert;Sara J. Fernandez

  • Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidence.

    Jessica Freiherr;Manfred Hallschmid;William H. Frey;Yvonne F. Brünner

  • TNF-α Mediates PKR-Dependent Memory Impairment and Brain IRS-1 Inhibition Induced by Alzheimer’s β-Amyloid Oligomers in Mice and Monkeys

    Mychael V. Lourenco;Julia R. Clarke;Rudimar L. Frozza;Theresa R. Bomfim

  • Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease

    Sergio T. Ferreira;Julia R. Clarke;Theresa R. Bomfim;Fernanda G. De Felice

  • Monoclonal antibodies that target pathological assemblies of Aβ

    Mary P. Lambert;Pauline T. Velasco;Lei Chang;Kirsten L. Viola

  • Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases.

    Sergio T. Ferreira;Marcelo N. N. Vieira;Fernanda G. De Felice

  • How does brain insulin resistance develop in Alzheimer's disease?

    Fernanda G. De Felice;Mychael V. Lourenco;Sergio T. Ferreira

  • Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer's disease.

    Sergio T. Ferreira;Mychael V. Lourenco;Mauricio M. Oliveira;Fernanda G. De Felice

  • Alzheimer's disease and insulin resistance: translating basic science into clinical applications

    Fernanda G. De Felice

  • Mitochondrial Bound Hexokinase Activity as a Preventive Antioxidant Defense STEADY-STATE ADP FORMATION AS A REGULATORY MECHANISM OF MEMBRANE POTENTIAL AND REACTIVE OXYGEN SPECIES GENERATION IN MITOCHONDRIA

    Wagner Seixas da-Silva;Armando Gómez-Puyou;Marietta Tuena de Gómez-Puyou;Rafael Moreno-Sanchez

  • Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer's disease.

    Natalia M. Lyra e Silva;Natalia M. Lyra e Silva;Rafaella A. Gonçalves;Rafaella A. Gonçalves;Rafaella A. Gonçalves;Tharick A. Pascoal;Ricardo A. S. Lima-Filho

  • Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System.

    Fernanda G. De Felice;Fernanda G. De Felice;Fernanda Tovar-Moll;Jorge Moll;Douglas P. Munoz

  • The Role of Leptin and Adiponectin in Obesity-Associated Cognitive Decline and Alzheimer's Disease.

    Leticia Forny-Germano;Fernanda G. De Felice;Fernanda G. De Felice;Marcelo Nunes do Nascimento Vieira

  • The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease

    Andre F. Batista;Leticia Forny-Germano;Julia R. Clarke;Natalia M. Lyra e Silva

  • Alzheimer's Disease-Like Pathology Induced by amyloid-β Oligomers in Nonhuman Primates

    Leticia Forny-Germano;Natalia M. Lyra E Silva;André F. Batista;Jordano Brito-Moreira

  • Targeting the neurotoxic species in Alzheimer’s disease: inhibitors of Aβ oligomerization

    Fernanda G De Felice;Marcelo N N Vieira;Leonardo M Saraiva;J Daniel Figueroa-Villar

Frequent Co-Authors

Sergio T. Ferreira
Sergio T. Ferreira Federal University of Rio de Janeiro
William L. Klein
William L. Klein Northwestern University
Douglas P. Munoz
Douglas P. Munoz Queen's University
Flávia Carvalho Alcantara Gomes
Flávia Carvalho Alcantara Gomes Federal University of Rio de Janeiro
Jose Donato
Jose Donato Universidade de São Paulo
Marco A. M. Prado
Marco A. M. Prado University of Western Ontario
Rosalia Mendez-Otero
Rosalia Mendez-Otero Federal University of Rio de Janeiro
Ottavio Arancio
Ottavio Arancio Columbia University
Antônio Lúcio Teixeira
Antônio Lúcio Teixeira The University of Texas Health Science Center at San Antonio
Vania F. Prado
Vania F. Prado University of Western Ontario

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Fernanda G. De Felice

Trending Scientists